JCR Avrasya Evaluates Biotrend, but Filing Gives No Rating Details
Biotrend said JCR Avrasya assessed the company; the KAP notice directs readers to an attached PDF for the detailed findings.
Makkler Newsroom · Oct 12, 06:38 PM · 1 min read
Market closed· · TRY · Data may be delayed
Not enough data
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO